HomeAI · summaries
Storia in 18 fonti
In win for RFK Jr., FDA advisory panel narrowly votes to allow compounding of unapproved peptides
The panel recommended allowing compounding pharmacies to produce popular but unproven BPC-157 and KPV peptides.
Confronto fonti
6 prospettive sulla stessa storiaTimeline cronologica
- ·
forbes.com
FDA’s Review Of Peptides Signals A Growing Public Health Challenge
A FDA advisory committee will review evidence surrounding peptides. Experts are concerned there is a paucity of evidence to back their approval for legal compounding.
- ·
cbc.ca
U.S. FDA panel to review 7 peptides amid growing popularity | CBC News
U.S. FDA advisers this week will weigh whether seven popular peptides can be compounded by licensed pharmacies, but even if regulators decline to expand access, industry…
